Differential expression of leukocyte immunoglobulin-like receptors on cord-blood-derived human mast cell progenitors and mature mast cells.
The leukocyte Ig-like receptors (LILRs) comprise a family of cell-surface immunoregulatory receptors with activating and inhibitory members. The inhibitory LILRs possess cytoplasmic ITIMs that down-regulate signaling by nonreceptor tyrosine kinase cascades. The activating members have a truncated cytoplasmic domain and signal through the FcR gamma chain. We examined the expression of LILRs on human mast cells during their development in vitro. Progenitor mast cells expressed cell surface inhibitory LILRB1, -B2, -B3, and -B4 and activating LILRA1. However, although mature cord blood-derived mast cells (hMCs) had detectable mRNA encoding multiple LILRs, none were expressed on the cell surface. Culture of progenitor mast cells or hMCs with various cytokine combinations failed to retain or induce cell surface expression of the LILRs. It is interesting that hMCs expressed LILRB5 in cytoplasmic granules and upon cross-linking of the high-affinity IgE receptor, released LILRB5 into the culture medium. Our results demonstrate that LILRs are developmentally regulated in human mast cells and that LILRB5 is expressed in mast cell granules and the release of soluble LILRB5 following IgE FcR-dependent stimulation, which has potential for amplification of mast cell-dependent, inflammatory responses.
Tedla
Nicodemus
N
Inflammatory Diseases Research Unit, School of Medical Sciences, University of New South Wales, Sydney, Australia. n.tedla@unsw.edu.au
Lee
Chyh-Woei
CW
Borges
Luis
L
Geczy
Carolyn L
CL
Arm
Jonathan P
JP
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D015703:Antigens, CD / Q000096:biosynthesis* / Q000235:genetics; D002454:Cell Differentiation / Q000235:genetics; D002478:Cells, Cultured / Q000187:drug effects / Q000378:metabolism; D016207:Cytokines / Q000494:pharmacology; D003594:Cytoplasmic Granules / Q000378:metabolism; D005312:Fetal Blood / Q000166:cytology*; D018507:Gene Expression Regulation, Developmental; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000378:metabolism*; D006801:Humans; D000075362:Leukocyte Immunoglobulin-like Receptor B1; D008407:Mast Cells / Q000378:metabolism*; D008562:Membrane Glycoproteins / Q000096:biosynthesis* / Q000235:genetics; D051379:Mice; D008807:Mice, Inbred BALB C; D012333:RNA, Messenger / Q000096:biosynthesis; D011940:Receptor Aggregation; D011956:Receptors, Cell Surface / Q000096:biosynthesis* / Q000235:genetics; D017455:Receptors, IgE / Q000502:physiology; D011971:Receptors, Immunologic / Q000096:biosynthesis* / Q000235:genetics; D011994:Recombinant Proteins / Q000494:pharmacology; D019089:Stem Cell Factor / Q000494:pharmacology
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D016207:Cytokines; C105298:LILRA2 protein, human; C105299:LILRB1 protein, human; C491341:LILRB2 protein, human; C527699:LILRB3 protein, human; C107907:LILRB4 protein, human; C527700:LILRB5 protein, human; D000075362:Leukocyte Immunoglobulin-like Receptor B1; D008562:Membrane Glycoproteins; D012333:RNA, Messenger; D011956:Receptors, Cell Surface; D017455:Receptors, IgE; D011971:Receptors, Immunologic; D011994:Recombinant Proteins; D019089:Stem Cell Factor; C413086:leukocyte-immunoglobulin--like receptor 6